Abstract

Streptococcal pneumoniae is a vaccine preventable disease but remains a leading cause of disease and death in the United States. In 2016, Streptococcal pneumoniae was responsible for 1.2 million deaths in over 195 countries. The illness is attributed to patients having invasive diseases, comorbid diseases, disability and death. The number of adults contracting Streptococcal pneumonia could be lowered dramatically with the use of proper vaccination, which is readily available. In 2022, the Center for Disease Control and the Advisory Committee on Immunization Practices (ACIP) release a new timing schedule and guidelines regarding the vaccination for pneumonia in the adult population. These guidelines included the latest approved pneumonia vaccination, Prevnar 20, which is the pneumococcal conjugate vaccine 20. This study primarily focused on provider knowledge and implementation of the latest guidelines in their respective clinical settings. The review of literature was limited due to the recent release of the ACIP guidelines for pneumococcal vaccination. However, the literature revealed pneumonia as a leading cause of death among adults and the safety and efficacy of the latest vaccination for pneumonia, Prevnar 20. A sample of 57 healthcare providers in clinical settings across Mississippi completed the 18-question questionnaire to determine knowledge and implementation. Results indicated that participants were not knowledgeable o the guidelines with a mean score of 4.54 and a score of 6 considered knowledgeable, but participants did recommend or offer pneumonia vaccines.

Degree

Master of Science in Nursing (MSN)

Department

Graduate Nursing

Degree Date

2023

First Advisor

Dr. Beth Turner

Second Advisor

Dr. Sueanne Davidson

Third Advisor

Dr. Lindsay Kemp

Document Type

Thesis

Comments

contributions by Joseph Salley

Download

Share

COinS